Mercy BioAnalytics Raises $59 Million Series B to Advance Cancer Detection Platform
The funding will support commercialization of the company’s extracellular vesicle-based liquid biopsy tests, starting with ovarian cancer screening.
Read More
Search Results for: liver disease
Randox Laboratories to Expand Jefferson County Facility Into Full Production Operation
The global diagnostics manufacturer plans to transform its West Virginia sales and distribution site into a manufacturing hub for next-generation diagnostic products.
Read More
New Nanoparticle System Triples CRISPR Gene-Editing Efficiency
DNA-wrapped lipid nanoparticles show improved cellular uptake and reduced toxicity compared to standard delivery methods used in COVID-19 vaccines.
Read More
10x Genomics Releases Xenium Protein for Integrated RNA-Protein Analysis
The spatial biology platform enables simultaneous detection of RNA and proteins in the same cell within a single automated workflow.
Read More
FDA Clears Tumor Profiling Assay that Analyzes 425 Cancer-Related Genes
The NGS-based test joins CE-IVD and NMPA approvals for global market access.
Read More